1. Home
  2. MI vs APLT Comparison

MI vs APLT Comparison

Compare MI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NFT Limited

MI

NFT Limited

HOLD

Current Price

$4.30

Market Cap

45.5M

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.22

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MI
APLT
Founded
2009
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.5M
38.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MI
APLT
Price
$4.30
$0.22
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$1.25
AVG Volume (30 Days)
6.3K
27.5M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$662,718.00
$1,000,000.00
Revenue This Year
N/A
$124.18
Revenue Next Year
N/A
$66.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$0.20
52 Week High
$8.61
$1.50

Technical Indicators

Market Signals
Indicator
MI
APLT
Relative Strength Index (RSI) 65.68 30.66
Support Level $3.87 $0.21
Resistance Level $4.10 $0.26
Average True Range (ATR) 0.20 0.03
MACD 0.09 0.02
Stochastic Oscillator 98.70 16.86

Price Performance

Historical Comparison
MI
APLT

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: